ATRC
Price
$35.17
Change
+$0.14 (+0.40%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.75B
32 days until earnings call
SIBN
Price
$14.04
Change
-$0.10 (-0.71%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
606.13M
44 days until earnings call
Interact to see
Advertisement

ATRC vs SIBN

Header iconATRC vs SIBN Comparison
Open Charts ATRC vs SIBNBanner chart's image
AtriCure
Price$35.17
Change+$0.14 (+0.40%)
Volume$4.41K
Capitalization1.75B
SI-BONE
Price$14.04
Change-$0.10 (-0.71%)
Volume$6.22K
Capitalization606.13M
ATRC vs SIBN Comparison Chart in %
Loading...
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRC vs. SIBN commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a StrongBuy and SIBN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ATRC: $35.03 vs. SIBN: $14.14)
Brand notoriety: ATRC and SIBN are both not notable
ATRC represents the Pharmaceuticals: Other, while SIBN is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ATRC: 57% vs. SIBN: 100%
Market capitalization -- ATRC: $1.74B vs. SIBN: $610.01M
ATRC [@Pharmaceuticals: Other] is valued at $1.74B. SIBN’s [@Medical/Nursing Services] market capitalization is $610.01M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.02B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.92B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.49B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRC’s FA Score shows that 0 FA rating(s) are green whileSIBN’s FA Score has 0 green FA rating(s).

  • ATRC’s FA Score: 0 green, 5 red.
  • SIBN’s FA Score: 0 green, 5 red.
According to our system of comparison, SIBN is a better buy in the long-term than ATRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRC’s TA Score shows that 4 TA indicator(s) are bullish while SIBN’s TA Score has 4 bullish TA indicator(s).

  • ATRC’s TA Score: 4 bullish, 5 bearish.
  • SIBN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SIBN is a better buy in the short-term than ATRC.

Price Growth

ATRC (@Pharmaceuticals: Other) experienced а -4.45% price change this week, while SIBN (@Medical/Nursing Services) price change was -6.85% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.23%. For the same industry, the average monthly price growth was -3.27%, and the average quarterly price growth was +8.57%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.72%. For the same industry, the average monthly price growth was +3.25%, and the average quarterly price growth was +9.80%.

Reported Earning Dates

ATRC is expected to report earnings on Oct 29, 2025.

SIBN is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-1.72% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATRC($1.75B) has a higher market cap than SIBN($606M). ATRC YTD gains are higher at: 14.627 vs. SIBN (0.214). ATRC has higher annual earnings (EBITDA): -9.24M vs. SIBN (-15.81M). SIBN has more cash in the bank: 146M vs. ATRC (118M). SIBN has less debt than ATRC: SIBN (36.9M) vs ATRC (77.3M). ATRC has higher revenues than SIBN: ATRC (500M) vs SIBN (185M).
ATRCSIBNATRC / SIBN
Capitalization1.75B606M289%
EBITDA-9.24M-15.81M58%
Gain YTD14.6270.2146,836%
P/E RatioN/AN/A-
Revenue500M185M270%
Total Cash118M146M81%
Total Debt77.3M36.9M209%
FUNDAMENTALS RATINGS
ATRC vs SIBN: Fundamental Ratings
ATRC
SIBN
OUTLOOK RATING
1..100
5952
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9495
PRICE GROWTH RATING
1..100
5264
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
9090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIBN's Valuation (37) in the Medical Specialties industry is in the same range as ATRC (66). This means that SIBN’s stock grew similarly to ATRC’s over the last 12 months.

SIBN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ATRC (100). This means that SIBN’s stock grew similarly to ATRC’s over the last 12 months.

ATRC's SMR Rating (94) in the Medical Specialties industry is in the same range as SIBN (95). This means that ATRC’s stock grew similarly to SIBN’s over the last 12 months.

ATRC's Price Growth Rating (52) in the Medical Specialties industry is in the same range as SIBN (64). This means that ATRC’s stock grew similarly to SIBN’s over the last 12 months.

ATRC's P/E Growth Rating (97) in the Medical Specialties industry is in the same range as SIBN (100). This means that ATRC’s stock grew similarly to SIBN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRCSIBN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 18 days ago
73%
Bullish Trend 29 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VPACX16.76N/A
N/A
Vanguard Pacific Stock Index Investor
AMRBX4.84N/A
N/A
American Growth One B
JEEBX17.07N/A
N/A
JHancock Infrastructure A
LAVSX16.86N/A
N/A
Lord Abbett Fundamental Equity R4
MENIX9.59N/A
N/A
Madison Covered Call & Equity Income I

ATRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with CERS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
-2.94%
CERS - ATRC
42%
Loosely correlated
-1.95%
SIBN - ATRC
41%
Loosely correlated
-0.56%
ISRG - ATRC
39%
Loosely correlated
-1.32%
IRMD - ATRC
38%
Loosely correlated
-2.39%
TMCI - ATRC
37%
Loosely correlated
-1.47%
More

SIBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with ATRC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then ATRC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
-0.64%
ATRC - SIBN
40%
Loosely correlated
+0.49%
TMCI - SIBN
40%
Loosely correlated
-0.30%
UFPT - SIBN
40%
Loosely correlated
+1.84%
DCTH - SIBN
40%
Loosely correlated
-1.06%
AVNS - SIBN
39%
Loosely correlated
+1.90%
More